CRYBB2
Beta-crystallin B2
Also known as: CCA2, CRBB2_HUMAN, CRYB2, CRYB2A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P43320
- Gene
- CRYBB2
- Ensembl
- ENSG00000244752
- Chromosome
- 22
- Canonical length
- 205 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Beta-crystallins, the most heterogeneous, differ by the presence of the C-terminal extension (present in the basic group, none in the acidic group). Beta-crystallins form aggregates of different sizes and are able to self-associate to form dimers or to form heterodimers with other beta-crystallins. This gene, a beta basic group member, is part of a gene cluster with beta-A4, beta-B1, and beta-B3. A chain-terminating mutation was found to cause type 2 cerulean cataracts. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
205 residues, UniProt reviewed canonical sequence.
>P43320|CRYBB2
1 MASDHQTQAG KPQSLNPKII IFEQENFQGH SHELNGPCPN LKETGVEKAG SVLVQAGPWV
61 GYEQANCKGE QFVFEKGEYP RWDSWTSSRR TDSLSSLRPI KVDSQEHKII LYENPNFTGK
121 KMEIIDDDVP SFHAHGYQEK VSSVRVQSGT WVGYQYPGYR GLQYLLEKGD YKDSSDFGAP
181 HPQVQSVRRI RDMQWHQRGA FHPSNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRYBB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 2.2 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 2.2 nTPM
- hippocampal formation: 2 nTPM
- testis: 1.8 nTPM
- cerebral cortex: 1.6 nTPM
- pituitary gland: 1.5 nTPM
- amygdala: 1.3 nTPM
Single-cell type
- late spermatids: 13 nCPM
- neutrophils: 6.3 nCPM
- endometrial glandular cells: 5.5 nCPM
- endometrial luminal cells: 5.4 nCPM
- medullary thymic epithelial cells: 4.8 nCPM
- breast secretory cells: 4.5 nCPM
Immune cell
- memory B-cell: 0.2 nTPM
- NK-cell: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- intermediate monocyte: 0.1 nTPM
Brain region
- cerebral cortex: 2.6 nTPM
- hypothalamus: 2.3 nTPM
- basal ganglia: 1.9 nTPM
- hippocampal formation: 1.9 nTPM
- thalamus: 1.8 nTPM
- pons: 1.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CRYBB2.
Disease | AllUniProt
Conditions CRYBB2 is implicated in, by any mechanism.
- Cataract 3, multiple types (CTRCT3) MIM:601547
Disease | GeneticClinVar
15 pathogenic / likely-pathogenic of 142 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cataract 3 multiple types
- Developmental cataract
- CRYBB2-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.39
- gnomAD missense Z
- 1.07
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CRYBB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRYBB2 as an antibody target. Whether an autoantibody or antibody against CRYBB2 could matter depends on whether native CRYBB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRYBB2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CRYBB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...